Vigilant Capital Management, LLC Organon & Co. Transaction History

Vigilant Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	SELL	$23.31 - $28.61 $23 - $28	-1 Reduced 0.94%	105 $3,000
Q3 2022 Oct 25, 2022	SELL	$23.4 - $34.25 $2,457 - $3,596	-105 Reduced 49.76%	106 $2,000
Q1 2022 Apr 07, 2022	SELL	$30.45 - $39.36 $15,864 - $20,506	-521 Reduced 71.17%	211 $7,000
Q4 2021 Jan 06, 2022	BUY	$28.67 - $37.13 $3,669 - $4,752	128 Added 21.19%	732 $22,000
Q3 2021 Oct 08, 2021	SELL	$28.63 - $35.64 $143 - $178	-5 Reduced 0.82%	604 $20,000
Q2 2021 Jul 09, 2021	BUY	$28.45 - $38.0 $17,326 - $23,142	609 New	609 $18,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Vigilant Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Vigilant Capital Management, LLC with notifications on news.